TECH
BIO-TECHNE Corp
Key Financials
Gross Profit
$790.3M
↑ 2.7%
Operating Income
$102.3M
↓ 50.5%
EPS (Diluted)
$0.46
↓ 56.2%
Net Income
$73.4M
↓ 56.3%
Revenue
$1.2B
↑ 5.2%
Total Assets
$2.6B
↓ 5.4%
Shareholders' Equity
$2.1B
↑ 5.2%
Dividends/Share
$0.32
0.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 5/12/2026 | View on SEC |
| 144 | 5/8/2026 | View on SEC |
| 4 | 5/7/2026 | View on SEC |
| 4 | 5/7/2026 | View on SEC |
| 4 | 5/7/2026 | View on SEC |
| 10-Q | 5/6/2026 | View on SEC |
| SCHEDULE 13G | 5/6/2026 | View on SEC |
| 8-K | 5/6/2026 | View on SEC |
| 4 | 5/5/2026 | View on SEC |
| SCHEDULE 13G | 4/29/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | TECH |
| Company Name | BIO-TECHNE Corp |
| CIK | 842023 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 0630 |
| State of Incorporation | MN |
| Phone | 612-379-8854 |